Oxcarbazepine Tablet, Film Coated
Product Images NDC 71335-0090

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Oxcarbazepine (NDC 71335-0090). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl713350090)

Label for Oxcarbazepine 300 mg oral film-coated tablets packaged by Bryant Ranch Prepack. The label states the product compares to Trileptal 300 mg tablets by LGM Pharma Solutions, LLC. It indicates a 30 tablet count, storage instructions at 20°-25°C (68°-77°F), and includes a barcode, NDC 71335-0090, and lot number 1523487.*

FDA Label Image

Chemical Structure (Oxcarbazepine 01)

Chemical structure of oxcarbazepine, showing a dibenzazepine core with a ketone group and a carbamoyl substituent attached to the nitrogen atom.*

FDA Label Image

Figure 1 (Oxcarbazepine 02)

A Kaplan-Meier plot showing exit rate over time from Day 2 to Day 11 for two treatment groups: Oxcarbazepine (solid line) and Placebo (dotted line). The plot includes a log-rank test with a p-value of 0.0001, indicating statistical comparison between groups. The x-axis represents time on trial in days, and the y-axis represents exit rate from 0.0 to 1.0.*

FDA Label Image

Figure 2 (Oxcarbazepine 03)

A Kaplan-Meier curve comparing seizure rates over time from first dose to first seizure between Oxcarbazepine and placebo treatment groups. The x-axis shows days from first dose (0 to 140), and the y-axis shows seizure rate (0 to 1.0). The Oxcarbazepine group has a lower seizure rate over time compared to placebo. A log-rank test p-value of 0.046 is noted on the chart.*

FDA Label Image

Figure 3 (Oxcarbazepine 04)

A step plot depicting exit rate over time to exit in days, comparing two treatment groups labeled 'HIGH' (solid line) and 'LOW' (dotted line). The x-axis shows days from 0 to 130, and the y-axis shows exit rate from 0.0 to 1.0. A log-rank test p-value of 0.0001 is noted on the graph, indicating statistical analysis of the differences between groups.*

FDA Label Image

Figure 4 (Oxcarbazepine 05)

A Kaplan-Meier survival curve graph depicting exit rate over time (days) for two treatment groups labeled HIGH and LOW, represented by solid and dotted lines, respectively. The graph includes a log-rank test p-value of 0.0001 indicating statistical comparison between the two groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.